Integer (ITGR) Soars 3.8%: Is Further Upside Left in the Stock?

Company Overview - Integer Holdings (ITGR) shares increased by 3.8% to close at $122.73, following a notable trading volume, despite a 15.2% loss over the past four weeks [1] - The company has a positive outlook for 2025, projecting 8%-10% sales growth and double-digit EPS growth, which has enhanced investor confidence [2] Financial Performance - Integer is expected to report quarterly earnings of$ 1.29 per share, reflecting a year-over-year increase of 13.2%, with revenues anticipated at $434.1 million, up 4.7% from the previous year [3] - The consensus EPS estimate for the upcoming quarter has been revised 3.4% lower over the last 30 days, indicating a negative trend in earnings estimate revisions [4] Strategic Positioning - Recent acquisitions in Electrophysiology, Neurovascular, and Surgical Robotics are projected to generate approximately$ 240 million in annualized sales, positioning the company for growth in high-demand therapeutic markets [2] - Integer's disciplined capital allocation and robust product development pipeline are expected to support sustained above-market growth, benefiting both patients and shareholders [2] Industry Context - Integer operates within the Zacks Medical - Instruments industry, where another company, KORU Medical Systems Inc. (KRMD), has seen a 0.9% increase in its stock price, although it has experienced a 30.7% decline over the past month [4] - KORU Medical's consensus EPS estimate remains unchanged at -$0.03, representing a 50% decrease compared to the previous year [5]